Seebri Breezhaler is a prescription medication used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It contains the active ingredient glycopyrronium bromide, which is a type of drug known as a long-acting muscarinic antagonist (LAMA). Seebri Breezhaler works by relaxing the muscles in the airways, thereby opening them and making it easier for the patient to breathe. It is administered through inhalation using a specific device called the Breezhaler, which is designed to deliver the medication directly to the lungs. This medication is intended for regular use and is not suitable for the immediate relief of acute breathing problems.